Review decisions
Showing 840 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00910
Product Type: Drug
Control Number: 247842
Manufacturer: BGP Pharma ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-12-23
Decision / Authorization Date: 2021-12-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00577
Product Type: Drug
Control Number: 259186
DIN(s): 02524031, 02527804
Manufacturer: Pfizer Canada ULC
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-12-01
Issued / Original Publication Date: 2022-02-28
Decision / Authorization Date: 2022-01-17
Updated Date: 2025-05-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00897
Product Type: Drug
Control Number: 246187
DIN(s): 02522845
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-11-09
Decision / Authorization Date: 2021-11-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00898
Product Type: Drug
Control Number: 246936
Manufacturer: BGP Pharma ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-11-30
Decision / Authorization Date: 2021-11-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00900
Product Type: Drug
Control Number: 247369
DIN(s): 02522829, 02522837
Manufacturer: Samsung Bioepis Co., Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-11-12
Decision / Authorization Date: 2021-11-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00955
Product Type: Drug
Control Number: 247561
DIN(s): 02522772
Manufacturer: SIGA Technologies, Inc.
Submission Type: Extraordinary Use New Drug Submission
Date Filed / Submission Date: 2020-12-22
Decision / Authorization Date: 2021-11-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00957
Product Type: Drug
Control Number: 247707
DIN(s): 02522470
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2021-11-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629
Product Type: Drug
Control Number: 259103
DIN(s): 02532891, 02532905, 02532913, 02532921, 02532948, 02532956, 02541041, 02541068, 02541076, 02541084, 02541092, 02541106, 02551950, 02551969, 02551977, 02551985, 02552000
Manufacturer: Eli Lilly Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-11-29
Issued / Original Publication Date: 2023-03-17
Decision / Authorization Date: 2022-11-24
Updated Date: 2025-10-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00909
Product Type: Drug
Control Number: 246933
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-11-30
Decision / Authorization Date: 2021-11-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00890
Product Type: Drug
Control Number: 253702
DIN(s): 02513153
Manufacturer: Janssen Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-06-14
Decision / Authorization Date: 2021-11-23